Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced sta...

Edwards Lifesciences Corp (EW) has a valuation score of 62/100 (moderate), profitability score of 77/100 (strong), financial health score of 100/100 (strong), Piotroski F-Score of 6/9, Altman Z-Score of 12.71 (safe zone), revenue growth of +4.1% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Aug 31, 2026

Analyst Recommendations40 analysts · 2026-08-01
13
17
10
Strong Buy 13Buy 17Hold 10Sell 0Strong Sell 0
Edwards Lifesciences Corp (EW) Valuation & P/E History →Edwards Lifesciences Corp (EW) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →